---
title: CDMO Daily News — August 29, 2026
slug: daily-news-2026-08-29-cdmo
site: cdmo
post_kind: news
byline: BioBM
description: August 29 CDMO daily: Evonik Invests $108M in Vancouver GMP Lipid Drug-Product Facility; Neuland, Gland Pharma Expand Sterile API Capacity via Visakhapatnam…
canonical_url: https://www.cdmo.directory/posts/daily-news-2026-08-29-cdmo
published_at: 2026-08-29T00:00:48.453Z
last_updated: 2026-08-29T00:01:28.797Z
---

### [Evonik](/companies/evonik) Invests $108M in Vancouver GMP Lipid Drug-Product Facility
- [Evonik](/companies/evonik) is building a new GMP drug-product manufacturing facility in Vancouver with over three times the capacity of its current site, targeting lipid-based therapeutics.
- The $150 million CAD investment ($108 million USD) is supported by $49 million CAD in Canadian federal government funding; production begins end of 2029.
- The facility will expand quality control and microbiological testing capabilities to accelerate product release for clinical and commercial use.

**Operational Impact**

[Evonik](/companies/evonik)'s Vancouver facility adds significant North American lipid drug-product capacity for biotech and pharma customers, with production commencing end of 2029 and enhanced QC/microbiological testing to accelerate clinical and commercial timelines.

*Source: [Contract Pharma Breaking News RSS](https://www.contractpharma.com/breaking-news/evonik-invests-108m-in-vancouver-gmp-facility)*

---

### Neuland, Gland Pharma Expand Sterile API Capacity via Visakhapatnam Partnership
- Gland Pharma will build a dedicated sterile API manufacturing suite at its Visakhapatnam JNPC facility exclusively for Neuland, adding ~1,400 kg annual capacity.
- The partnership combines Neuland's complex API expertise with Gland's aseptic manufacturing capabilities, enabling integrated development-to-commercial supply for customers.
- The suite will operate to cGMP, USFDA, and EU standards, supporting Neuland's growing demand for sterile API products.

**Operational Impact**

Neuland gains dedicated sterile API capacity at Gland's Visakhapatnam JNPC facility, reducing outsourcing fragmentation and enabling single-partner integrated development-to-commercial supply for sterile API customers.

*Source: [Web search](https://www.contractpharma.com/breaking-news/neuland-gland-pharma-partner-on-sterile-api-manufacturing)*

## References

1. [Contract Pharma Breaking News RSS — Evonik Invests $108M in Vancouver GMP Lipid Drug-Product Facility](https://www.contractpharma.com/breaking-news/evonik-invests-108m-in-vancouver-gmp-facility)
2. [Web search — Neuland, Gland Pharma Expand Sterile API Capacity via Visakhapatnam Partnership](https://www.contractpharma.com/breaking-news/neuland-gland-pharma-partner-on-sterile-api-manufacturing)

Source: https://www.cdmo.directory/posts/daily-news-2026-08-29-cdmo